Giulia Casorati CD1-MR1 2024

Abstracts this author is presenting:

• Adoptive cell therapy of hematological malignancies across MHC-barriers by iNKT cells engineered with a CD1c-restricted TCR — Scientific Program 11 - Tumour Immunity